Ann: Clinical Trial for BodyGuard Technology, page-63

You've raised an old point that's now turned from "a nothing" into a concern. That point is simply that Technological obsolesce in now underway.

This is something that over the last 3 years I have tried to engage board member's about, and hoped I would not be predicting the outcome we are now facing.

What I'm referring to is the opportunity time for OBJ to utilize the competitive advantage of their technology against competitors. - I.e "Getting the product out there and getting paid for it" BEFORE competitors catch up.

Things are not progressing fast enough for OBJ to fully gain all that it deserves, and it does deserve a whole lot better that its measly little 0.069 share price.

The company has well over 10 years now of R&D. For much of that it, competitors did not have products, nor technology to match, and a major advantage existed. Now those competitors are creeping forward at a rate faster than OBJ can counter. This was ALWAYS going to be inevitable, that's the nature of tech business. But its a killer if you haven't got your foundations set into the market, and this is exactly where OBJ is at. It cant wait any longer, it has no established market foundation.

I have no doubt that OBJ tech is vastly superior to its competitors. We know that, we can see it in various studies, trials and reports. But if OBJ cant get the tech to market soon, and are the last to the party, then that superiority will evaporate, and it wont have the market impact it should. The saying "Strike while the iron is hot" is all to true.

In the multiple inquiries Ive made to board members over the years, all have failed to satisfy me that any business plan is taking this into account. I'm concerned they are not aware that they are loosing market share as this is being read, and not driving hard enough to get things done. They need to pull the proverbially lead out. 3m, P&G, COTY, R&B, J&J, whoever the hell has come and gone over the years, it doesn't matter. They have to lobby any prospective partner to get things moving much faster, and not a allow slave-master mentality to exist.

OBJ should have been an investors dream at $1 stock this year, 50c last year and 20 cent the year before. But delay, after delay, after delay, (like clockwork, and now predictable) is destroying the company by allowing competitors to erode their market, and close the tech gap advantage OBJ HAD. It's why genuinely good "price sensitive" announcements can, are, and will disregarded by the market as more fluff, and aren't why institutional investors aren't interested.

Point in case with the recent announcement- its just more license's to some unknown companies, for some unknown product, sometime in the future. So guess what the market says- "I've heard it before 100 times from OBJ, it went nowhere before, it will go nowhere now, so who the hell cares? - NEXT!".

Concernedly we have a mention for more trials for bodyguard?, this was supposed to "ready to market"? so now one not cant help but worry its a phase 1,2,3 and 7 years to go. delay, delay, delay, delay.

If if its a full phase triel, then that's an absolute and total failure, making bodyguard dead and finished before it starts. It will be lucky to make a hidden shelf of a local chemist store ever. Why?- because I guarantee you that in 7 years there will be a slew of equally alternative products all ready in the market. Even a 6 month trial is too long. We need it to market by Mid year.

Just like the announcements for all other trials, products, studies, licenses, agreements, etc, etc, - In 10 years not one announcement has translated to any worthwhile income for the company.

Any more delays over than 6 months from now will see OBJ entire market segments begin to significantly deteriorate. Its why Ive said I'll be out if they foretasted revenue streams done eventuate by mid this year.

Of course this is all my opinion, and I could be wrong. Maybe behind the scenes we have had 20mill of revenue already, and on our way to 50 next year. Maybe our products are weeks away from market shelf's on mass, in multiple big name brands, maybe the next two 4c's will prove my concerns as worthless, maybe this is already being achieved, and about to be reported... However

An absurd and terrible lack of transparency for shareholders means a very high degree of caution and skepticism will remain in the market, which much of it expecting company survival to be less than 3 years.

The market is demanding one very simple thing from a company. "Show me the money.. Show me the money NOW". If it can, the old 35c prediction is an easy target, if it cant.... well that's not good for anyone.

Only time will tell.

I'll ask the board for comments and response to this, and post if they approve. Lets hope its not a "wait a bit longer" response.